We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

19 hedge funds and large institutions have $2.35M invested in Sonoma Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

36% more funds holding

Funds holding: 14 → 19 (+5)

25% more capital invested

Capital invested by funds: $1.88M → $2.35M (+$474K)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
19
Holders Change
+5
Holders Change %
+35.71%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$197K
2
OC
Oppenheimer & Co
New York
+$117K
3
VKH
Virtu KCG Holdings
New York
+$39.9K
4
CS
Credit Suisse
Switzerland
+$34.6K
5
DADC
D.A. Davidson & Co
Montana
+$5.32K

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$157K
2
Morgan Stanley
Morgan Stanley
New York
-$87.7K
3
BA
Bard Associates
Illinois
-$69.1K
4
BRWA
B. Riley Wealth Advisors
Florida
-$53.2K
5
BIM
Bogle Investment Management
Massachusetts
-$50K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
Bard Associates
Illinois
$708K -$69.1K -26 -10%
Vanguard Group
2
Vanguard Group
Pennsylvania
$632K +$197K +74 +58%
Morgan Stanley
3
Morgan Stanley
New York
$307K -$87.7K -33 -25%
BIT
4
BlackRock Institutional Trust
California
$236K -$157K -59 -44%
BRWA
5
B. Riley Wealth Advisors
Florida
$144K -$53.2K -20 -30%
OC
6
Oppenheimer & Co
New York
$139K +$117K +44 New
VKH
7
Virtu KCG Holdings
New York
$46K +$39.9K +15 New
CS
8
Credit Suisse
Switzerland
$40K +$34.6K +13 New
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$33K – – –
Bank of America
10
Bank of America
North Carolina
$16K – – –
Bank of Montreal
11
Bank of Montreal
Ontario, Canada
$15K – – –
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$11K – – –
U
13
UBS
Switzerland
$6K -$5.32K -2 -50%
Wells Fargo
14
Wells Fargo
California
$5K – – –
1IC
15
1919 Investment Counsel
Maryland
$5K +$2.66K +1 New
DADC
16
D.A. Davidson & Co
Montana
$4K +$5.32K +2 New
LTFS
17
Ladenburg Thalmann Financial Services
Florida
$2K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$2K +$2.66K +1 New
CCM
19
Chilton Capital Management
Texas
$1.75K – – –
Citigroup
20
Citigroup
New York
$1K – – –
OIA
21
Optimum Investment Advisors
Illinois
$1K – – –
BIM
22
Bogle Investment Management
Massachusetts
– -$50K -21 Closed

SNOA Hedge Fund Activity: Q4 2013 in Review

19 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q4 2013, worth a combined $2.35M — up 25% from $1.88M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new SNOA positions and 1 closed out — a net gain of 5 holders — while 1 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $197K. The largest seller was BlackRock Institutional Trust, cutting an estimated $157K.

  • 19 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q4 2013, up from 14 in Q3 2013.
  • Funds reported $2.35M of Sonoma Pharmaceuticals stock for Q4 2013, up 25% quarter-over-quarter.
  • 6 funds opened new Sonoma Pharmaceuticals positions in Q4 2013 and 1 closed out, a net change of +5 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q4 2013 was Vanguard Group, an estimated $197K added.
  • The largest Sonoma Pharmaceuticals seller in Q4 2013 was BlackRock Institutional Trust, an estimated $157K sold.

Based on aggregated 13F filings for Q4 2013.